论文信息 - Duration of First-line Treatment with Molecular Targeted-Therapy Is a Prognostic Factor in Metastatic Renal Cell Carcinoma. - 字舞流文

Duration of First-line Treatment with Molecular Targeted-Therapy Is a Prognostic Factor in Metastatic Renal Cell Carcinoma.

K. Ueda | Shigetaka Suekane | T. Igawa | Mitsunori Matsuo | Makoto Nakiri | Naoyuki Ogasawara | Hirofumi Kurose | Kiyoaki Nishihara | Katsuaki Chikui | S. Hayashi | S. Suyama | S. Suekane | H. Kurose | M. Nakiri | K. Nishihara | Shunsuke Suyama